معرفی
Michele Cea is an Associate Professor in the Department of Internal Medicine and Medical Specialties - DIMI at the University of Genoa, affiliated with the School of Medical and Pharmaceutical Sciences. He serves as a Department Quality Assurance Manager and is a Member of the School Council and Department Board. His research focuses on hematology, particularly multiple myeloma, acute myeloid leukemia, and NAD+ metabolism in cancer therapies.
Recent publications highlight his work on measurable residual disease in secondary AML, CD56 expression in predicting therapeutic responses, and frailty-based mortality determinants in older myeloma patients. His studies often bridge clinical outcomes with metabolic profiling, emphasizing personalized treatment strategies.
He teaches Blood Diseases and related courses across medical specializations, including hematology, pediatrics, and oncology programs. While no scientific awards are explicitly mentioned, his leadership roles in academic governance and clinical research underscore his institutional impact.